[Inflammation and ischaemic stroke: current status and future perspectives].

Area of Science:

• Neuroscience
• Immunology
• Pathophysiology

Context:

• Acute ischemic stroke involves complex inflammatory responses with potential detrimental or beneficial effects on patient outcomes.
• Somatic markers like body temperature and C-reactive protein show correlations with stroke outcomes, but data are often contradictory due to complex kinetics.
• Key inflammatory effectors include cellular adhesion molecules, leukocytes, microglia, and blood-brain barrier permeability.

Purpose:

• To review the current understanding of inflammation effector pathways in focal cerebral ischemia.
• To explore therapeutic perspectives targeting inflammatory responses in acute stroke.
• To highlight the need for better understanding of inflammatory pathophysiology for improved clinical trial design.

Summary:

• Inflammation plays a critical role in acute ischemic stroke, with complex cascade phenomena influencing outcomes.
• While studies on anti-adhesion molecules and hypothermia have yielded disappointing results, recent research suggests potential benefits from insulin and statins via their anti-inflammatory effects.
• Understanding the intricate inflammatory pathophysiology is essential for advancing therapeutic strategies and designing more effective clinical trials for stroke patients.

Impact:

• Provides a comprehensive overview of inflammation's role in ischemic stroke, guiding future research directions.
• Identifies promising therapeutic avenues, including insulin and statins, for managing stroke-related inflammation.
• Emphasizes the importance of refined clinical trial designs based on a deeper understanding of neuroinflammation in stroke.